RSV
Clinical trials for RSV explained in plain language.
Never miss a new study
Get alerted when new RSV trials appear
Sign up with your email to follow new studies for RSV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human tests begin for new RSV shot using mRNA technology
⭐️ VACCINE ⭐️ Not yet recruitingThis is an early safety study for a new vaccine designed to protect against Respiratory Syncytial Virus (RSV). The trial will enroll 60 healthy adults to test different doses of a freeze-dried mRNA vaccine. Researchers will closely monitor participants for any side effects after …
Matched conditions: RSV
Phase: PHASE1 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 02, 2026 03:42 UTC
-
One swab, five viruses: new At-Home test aims for fast answers
Diagnosis Not yet recruitingThis study is checking if a new at-home test kit works as well as a lab test for finding common respiratory viruses. The kit checks for COVID-19, flu A, flu B, RSV, and the common cold virus (rhinovirus). Researchers will enroll 2,000 people in the U.S. who currently have cold or…
Matched conditions: RSV
Phase: NA • Sponsor: Aptitude Medical Systems • Aim: Diagnosis
Last updated Mar 23, 2026 15:18 UTC
-
Silent threat: study aims to uncover RSV's true toll on adults
Knowledge-focused Not yet recruitingThis study aims to measure how often and how severely Respiratory Syncytial Virus (RSV) affects adults in Hong Kong. Researchers will enroll up to 10,000 adults with respiratory symptoms to collect samples and track health outcomes. The goal is to get a clearer picture of RSV's t…
Matched conditions: RSV
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC